You are correct - thus far there has been no off-take agreement for the MHP from Acoje between Rusina and JXTC - it is still far too early.
First we need the trial on the pilot plant to complete to all stakeholders satisfaction, then they will complete the BFS, and then agreements can be reached as part of the overall funding package. So this is some way off in the grand scheme of things.
The DMCI DSO sales will occur on an opportunity basis and have no connection with the value-added HL benefication trials. So yes, I would have thought there is likely to be some news on the DSO front from time to time.
